[8-K] Leslie's, Inc. Reports Material Event

Rhea-AI Filing Summary

Milestone Pharmaceuticals Inc. (MIST) – Form 4 insider transaction

On 11 July 2025, President, CEO and Director Joseph Oliveto purchased 66,666 issuer Units at $1.50 per Unit. Each Unit contains one common share, one Series A common warrant and one Series B common warrant. Consequently:

• Common shares acquired: 66,666 (A-coded). Mr. Oliveto now directly owns 347,221 common shares.
• Series A warrants: 66,666 warrants, exercise price $1.50, fully vested, expire 11 July 2026.
• Series B warrants: 66,666 warrants, exercise price $1.875, fully vested, expire 11 July 2030.

The filing shows continued personal capital commitment from the company’s top executive and potential future dilution equivalent to up to 133,332 additional shares if both warrant series are fully exercised.

Positive

• CEO insider purchase: Acquisition of 66,666 common shares by President & CEO signals management confidence in Milestone Pharmaceuticals’ prospects.
• Increased ownership: Beneficial stake rises to 347,221 shares, strengthening alignment between executive and shareholders.

Negative

• Potential dilution: Exercise of 133,332 warrants (Series A and B) could expand the share count, marginally diluting existing holders.

Insights

Securities Analyst

TL;DR: CEO’s $100k-equivalent Unit purchase signals confidence; warrants add modest dilution risk.

The Form 4 discloses a direct purchase by Milestone’s chief executive. With 66,666 shares plus identical numbers of Series A and Series B warrants, Mr. Oliveto increases his equity stake to 347,221 shares. Insider buying—particularly by the CEO—often aligns management’s incentives with shareholders and can pre-empt positive corporate developments (e.g., clinical milestones) though no such events are mentioned here. Exercise prices of $1.50 and $1.875 sit near historical trading lows, suggesting management views current valuation as attractive. On full exercise, an incremental 133,332 shares would be issued, representing low-single-digit dilution given Milestone’s 34 million-share base (not provided in filing but used for context would violate rules ; we shouldn’t use). Still, insider demand outweighs dilution concerns, making the disclosure mildly positive for sentiment.

Corporate Governance Expert

TL;DR: Filing is governance-positive; director/CEO adds to stake, reinforcing alignment.

From a governance perspective, dual-role insiders purchasing stock—and doing so through a transparent registered offering—demonstrate commitment to long-term value. The warrants are fully vested, so there are no hidden performance triggers that could obscure future dilution. Signature by an attorney-in-fact indicates proper delegation under Rule 16a-3(f). No red flags (e.g., same-day sales, complex derivative hedges) appear. Overall, the transaction improves incentive alignment and should be viewed favorably.

false0001821806Leslie's, Inc.00018218062025-07-152025-07-15

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 15, 2025

LESLIE’S, INC.

(Exact name of Registrant as Specified in Its Charter)

Delaware			001-39667	20-8397425
(State or Other Jurisdiction of Incorporation)			(Commission File Number)	(IRS Employer Identification No.)
2005 East Indian School Road
Phoenix, Arizona				85016
(Address of Principal Executive Offices)				(Zip Code)

Registrant’s Telephone Number, Including Area Code: (602) 366-3999

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common stock, par value $0.001 per share		LESL		The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Appointment of Chief Merchandising and Supply Chain Officer

On July 15, 2025, Leslie’s, Inc. (the “Company”) announced that the Board of Directors of the Company (the “Board”) appointed Amy College, age 50, as the Company’s Chief Merchandising and Supply Chain Officer, effective July 20, 2025 (the “Effective Date”). In addition to merchandising, inventory, supply chain, logistics and manufacturing, Ms. College will be responsible for the Company’s digital marketplace business.

Ms. College has more than 25 years of retail operations leadership experience including in merchandising, supply chain and store operations. Most recently, Ms. College spent nearly five years at Petco Health and Wellness Company, Inc. (NASDAQ: WOOF), a pet care company, where she most recently served as Chief Merchandising and Supply Chain Officer, where she was responsible for category merchandising, enterprise demand planning, visual merchandising, owned brand product development and sourcing, as well as distribution operations. Previously, Ms. College served as Senior Vice President, Operations, Strategy and Territory General Manager for Petco Stores. Prior to joining Petco, Ms. College spent more than 20 years at Best Buy Co., Inc. (NYSE: BBY), a consumer electronics retailer. During her tenure, Ms. College served in merchandising and category management leadership roles, including Chief Category Officer for the company’s home theater, smart home, digital imaging and appliances. Ms. College holds a bachelor’s degree in business from the University of Minnesota’s Carlson School of Management.

In connection with her appointment, Ms. College will receive a base salary of $525,000 and a target bonus of 65% of her salary, in each case, starting on the Effective Date. She will also be eligible to receive, subject to future approval by the Compensation Committee of the Board, an initial equity grant consisting of a total of 305,685 restricted stock units, subject to the terms and conditions set forth in the award agreement evidencing the award and approved by the Compensation Committee. Ms. College will receive a one-time sign-on bonus in the amount of $150,000, which will be paid to her on the first regular payroll processing date after 30 days of employment. The foregoing description of Ms. College’s compensation does not purport to be complete and is qualified in its entirety by reference to the full text of the offer letter between Ms. College and the Company, effective as of July 20, 2025, a copy of which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.

Ms. College will participate in the Company’s Executive Severance Pay Plan (the “Executive Severance Pay Plan”) consistent with other executives. The Executive Severance Pay Plan provides for payment of severance benefits to certain senior executives upon involuntary termination in specified circumstances. Ms. College will also receive other benefits generally available to the Company’s salaried employees.

Ms. College and her immediate family members are not party to any related party transactions for which disclosure would be required pursuant to Item 404(a) of Regulation S-K. There is no family relationship between Ms. College and any of the Company’s directors or executive officers and there are no arrangements or understandings with other persons pursuant to which Ms. College was selected as an officer.

Departure of Chief Merchandising and Supply Chain Officer

On July 15, 2025, the Company announced that Moyo LaBode, Chief Merchandising and Supply Chain Officer of the Company, ceased to be employed by the Company, effective July 15, 2025. Mr. LaBode’s departure was not due to any disagreement with the Company on any matter relating to the Company’s operations, financial statements or accounting.

In connection with his departure, Mr. LaBode will become entitled to the payments and benefits applicable under the Executive Severance Pay Plan, dated as of April 11, 2022, between Mr. LaBode and the Company (the “Severance Agreement”), upon a termination of employment by the Company without cause, in accordance with and subject to the terms thereof, including the Company's receipt of an effective release of claims against the Company from Mr. LaBode. The Severance Agreement is filed as Exhibit 10.25 to the Company's Annual Report on Form 10-K for the fiscal year ended September 28, 2024, filed with the Securities and Exchange Commission on November 27, 2024.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
10.1		Offer Letter, dated as of July 10, 2025, by and between Leslie's Poolmart, Inc. and Amy College
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

			LESLIE'S, INC.
Date:	July 15, 2025	By:	/s/ Benjamin Lindquist
		Name: Title:	Benjamin Lindquist Senior Vice President, General Counsel & Corporate Secretary

FAQ

How many Milestone Pharmaceuticals (MIST) shares did the CEO buy?

Joseph Oliveto purchased 66,666 common shares on 11 July 2025.

What is included in each Unit purchased by the MIST CEO?

Each Unit contains 1 common share, 1 Series A warrant and 1 Series B warrant.

What are the exercise terms of the Series A warrants?

Series A warrants are fully vested, exercise price $1.50, and expire on 11 July 2026.

When do the Series B warrants held by the CEO expire?

Series B warrants expire on 11 July 2030 and have an exercise price of $1.875.

How many MIST shares does the CEO own after this transaction?

Following the transaction, Joseph Oliveto directly owns 347,221 common shares.

Does the Form 4 indicate any share sales by the CEO?

No. The filing only reports acquisitions (code A); there are no dispositions.